After demonstrating that IDO deficiency is associated with imbalanced Th17 and Treg populations in a murine model of CF, Ianitti et al. successfully corrected helper T cell populations and resolved inflammation by IDO restoration therapy. The gene discussed is IDO1; the disease is cystic fibrosis.